Portfolio Update

RNS Number : 4930I

Intl. Biotechnology Trust PLC

21 March 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 28 February 2018

Net Assets	£227m
Net Assets per share	605p
Share price	586p
Total value of unquoted investments	£22m
Total number of portfolio companies	95
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Array	4.7
Biogen	4.2
Celgene	4.2
Neurocrine	4.2
Regeneron	3.7
Genmab	3.7
Sage	3.6
Vertex	3.6
Gilead	3.3
Exelixis	3.2
	-----------
Total	38.4

Geographical Allocation	% NAV
US & Canada	89
Europe & UK	11
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	36
Mid Cap =USD1-10BN	37
Small Cap <USD1BN	27
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	38
Rare diseases	15
CNS	14
Inflammation	6
Ophthalmology	6
Metabolic	5
Infectious Diseases	4
Medtech	4
Other	8
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

21 MARCH 2018

 

END

 

 

PFUBUGDXSBDBGIB